Updated efficacy and safety from the global phase II NP28673 study of alectinib in patients (pts) with previously treated ALK+ non-small-cell lung cancer (NSCLC)
Year: 2016
Type: article
Source: Annals of Oncology
Authors: F. Barlesi, A.-M.C. Dingemans, J.C.-H. Yang, S.-H.I. Ou, J.S. Ahn, L. De Petris, B. Hughes, H. Lena, W. Bordogna, S. Golding, P.N. Morcos, B. Balas, A. Zeaiter, D.-W. Kim
Institutions: Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, Maastricht University Medical Centre, National Taiwan University, University of California, Irvine, Samsung Medical Center, Karolinska University Hospital, Prince Charles Hospital, Centre Hospitalier Universitaire de Rennes, F. Hoffmann-La Roche AG, Seoul National University, Seoul National University Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2586673947